D-0476-2024 Class II Ongoing
FDA drug recall D-0476-2024 was initiated by Imprimis NJOF, LLC on April 10, 2024 and is designated Class II. Reason for recall: Subpotent Drug The recall status is ongoing. Affected quantity: 3320 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- May 8, 2024
- Initiation Date
- April 10, 2024
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3320 bottles
Product Description
Prednisolone Sodium Phosphate-Moxifloxacin-Bromfenac Sterile Ophthalmic Solution 1%, 0.5%, 0.075%, 8mL, Compounded By: Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B Ledgewood, NJ 07852, NDC 71384-340-08
Reason for Recall
Subpotent Drug
Distribution Pattern
U.S. Nationwide
Code Information
Lot #: 23JUN031; Exp. 07/03/2024